Release Date: 12/10/17 12:09 Summary: Initial Results of 2017 Drill Program at BVS in Woolgar Price Sensitive: Yes Download Document 2.04MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%